Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jun 6;37(22):e177.
doi: 10.3346/jkms.2022.37.e177.

The Assessment and Outcomes of Crossmatching in Lung Transplantation in Korean Patients

Ha Eun Kim  1 , Young Ho Yang  1 , Hyo Chae Paik  1 , Su Jin Jeong  2 , Song Yee Kim  3 , Moo Suk Park  3 , Jin Gu Lee  4
Affiliations
Multicenter Study

The Assessment and Outcomes of Crossmatching in Lung Transplantation in Korean Patients

Ha Eun Kim et al. J Korean Med Sci. .

Abstract

Background: In lung transplantation, human leukocyte antigen (HLA) compatibility is not included in the lung allocation score system or considered when placing donor allografts. However, HLA matching may affect the outcomes of lung transplantation. This study evaluated the current assessment status, prevalence, and effects of HLA crossmatching in lung transplantation in Korean patients using nationwide multicenter registry data.

Methods: Two hundred and twenty patients who received lung transplantation at six tertiary hospitals in South Korea between March 2015 and December 2019 were retrospectively reviewed. Clinical data, including general demographic characteristics, primary diagnosis, and pretransplant status of the recipients and donors registered by the Korean Organ Transplant Registry, were retrospectively analyzed. Survival analysis was performed using the Kaplan-Meier method with log-rank tests.

Results: Complement-dependent cytotoxic crossmatch (CDC-XM) was performed in 208 patients (94.5%) and flow cytometric crossmatch (flow-XM) was performed in 125 patients (56.8%). Among them, nine patients (4.1%) showed T cell- and/or B cell-positive crossmatches. The incidences of postoperative complications, including primary graft dysfunction, acute rejection, and chronic allograft dysfunction in positively crossmatched patients, were not significant compared with those in patients without mismatches. Moreover, Kaplan-Meier analyses showed poorer 1-year survival in patients with positive crossmatch according to CDC-XM (P < 0.001) and T lymphocyte XM (P = 0.002) than in patients without mismatches.

Conclusion: Positive CDC and T lymphocyte crossmatching results should be considered in the allocation of donor lungs. If unavailable, the result should be considered for postoperative management in lung transplantation.

Keywords: Allocation; Crossmatching; Histocompatibility; Lung Transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1. Impact of positive crossmatching on survival of lung transplant patients. (A) The 1-year and (B) overall survival of lung transplant patients.
Fig. 2
Fig. 2. Impact of positive CDC and flow crossmatches on survival of lung transplant patients. (A) The 1-year survival according to the results of CDC crossmatch. (B) Overall survival according to the results of CDC crossmatch. (C) The 1-year survival according to the results of flow cytometric crossmatch. (D) Overall survival according to the results of flow cytometric crossmatch.
CDC = complement-dependent cytotoxicity.
Fig. 3
Fig. 3. Survival analysis of positive T and B lymphocyte crossmatches in lung transplantation. (A) The 1-year survival according to the results of T lymphocyte crossmatching. (B) Overall survival according to the results of T lymphocyte crossmatching. (C) The 1-year survival according to the results of B lymphocyte crossmatching. (D) Overall survival according to the results of B lymphocyte crossmatching.
See this image and copyright information in PMC

References

    1. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969;280(14):735–739. - PubMed
    1. Opelz G, Döhler B, Süsal C. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study. Hum Immunol. 2009;70(8):627–630. - PubMed
    1. Tinckam KJ, Chandraker A. Mechanisms and role of HLA and non-HLA alloantibodies. Clin J Am Soc Nephrol. 2006;1(3):404–414. - PubMed
    1. Fidler SJ, Irish AB, Lim W, Ferrari P, Witt CS, Christiansen FT. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. Transpl Immunol. 2013;28(4):148–153. - PubMed
    1. Leech SH, Rubin S, Eisen HJ, Mather PJ, Goldman BI, McClurken JB, et al. Cardiac transplantation across a positive prospective lymphocyte cross-match in sensitized recipients. Clin Transplant. 2003;17(Suppl 9):17–26. - PubMed

Publication types